Remibrutinib is a covalent Bruton's tyrosine kinase (BTK)
inhibitor. Also known as Remibrutinib (investigational/recently approved BTK
inhibitor). ApiSyn undertakes custom synthesis and process development for
complex molecules of this type, and any supply is subject to patent/licensing
review; no availability is implied.
| Chemical Name | N-(3-(6-amino-5-(2-(N-methylacrylamido)ethoxy)pyrimidin-4-yl)-5-fluoro-2-methylphenyl)-4-cyclopropyl-2-fluorobenzamide |
| Molecular Formula | C27H27F2N5O3 |
| Molecular Weight | 507.5 |
| CAS Number | 1787294-07-8 |